Blog

16 03, 2016

COPD Symposium Online!

2020-02-12T00:45:38+00:00

COPD Symposium Online! I’ve been slow to catch up to this development even though I’ve been a part of it. Each year, the European Respiratory Society holds its annual scientific meeting to share late-breaking news in the field of respiratory medicine. It’s a sprawling meeting hosting more than 20,000 international attendees who may [...]

COPD Symposium Online!2020-02-12T00:45:38+00:00
14 05, 2014

Inspiration Research Contributes to Groundbreaking Study

2019-06-18T23:57:42+00:00

Inspiration Research Contributes to Groundbreaking Study KAMADA Pharmaceutical ("Kamada") conducted a Phase II/III clinical trial on the efficacy of proprietary inhaled Alpha-­1 Antitrypsin (AAT) therapy for the treatment of Alpha-­1 Antitrypsin Deficiency (AATD or inherited emphysema) which involved a multi-centre, randomized, double-blind, placebo-controlled study designed to evaluate Kamada's formulation of human AAT to [...]

Inspiration Research Contributes to Groundbreaking Study2019-06-18T23:57:42+00:00

Inspiration Research Limited

Since inception, Inspiration Research has participated in developing of several leading treatment for asthma and COPD patients, such as Onbrez and Seebri Breezhaler. Currently, IRL specializes in clinical studies with patients diagnosed with asthma, heart disease and COPD. In addition, IRL operates a pulmonary function test laboratory that is occasionally open on Saturdays. Pulmonary function tests are valuable tools for doctors to diagnose patients with asthma, COPD, and other respiratory disease.

© All rights reserved, Inspiration Research Limited, 2019
Web development by Web Sharks
Go to Top